5.11
price down icon1.92%   -0.10
after-market After Hours: 5.11
loading
Optimizerx Corp stock is traded at $5.11, with a volume of 84,765. It is down -1.92% in the last 24 hours and down -32.23% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$5.21
Open:
$5.2
24h Volume:
84,765
Relative Volume:
0.70
Market Cap:
$93.62M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-6.2317
EPS:
-0.82
Net Cash Flow:
$153.00K
1W Performance:
-7.43%
1M Performance:
-32.23%
6M Performance:
-51.88%
1Y Performance:
-39.81%
1-Day Range:
Value
$5.05
$5.27
1-Week Range:
Value
$5.0435
$5.59
52-Week Range:
Value
$5.0435
$16.64

Optimizerx Corp Stock (OPRX) Company Profile

Name
Name
Optimizerx Corp
Name
Phone
248-651-6558
Name
Address
260 CHARLES STREET, WALTHAM, MI
Name
Employee
136
Name
Twitter
@OpRxTweets
Name
Next Earnings Date
2024-11-13
Name
Latest SEC Filings
Name
OPRX's Discussions on Twitter

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-02-23 Resumed B. Riley Securities Buy
Nov-01-22 Initiated Stifel Buy
Jul-15-22 Initiated SVB Leerink Outperform
Oct-18-21 Resumed B. Riley Securities Buy
Apr-13-21 Initiated RBC Capital Mkts Outperform
Jan-03-19 Initiated William Blair Outperform
View All

Optimizerx Corp Stock (OPRX) Latest News

pulisher
Nov 01, 2024

Rice Hall James & Associates LLC Boosts Holdings in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

OptimizRx stock hits 52-week low at $5.42 amid market challenges - Investing.com India

Nov 01, 2024
pulisher
Oct 31, 2024

OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET - The Manila Times

Oct 31, 2024
pulisher
Oct 21, 2024

Optimizerx stock hits 52-week low at $6.29 amid market shifts - Investing.com

Oct 21, 2024
pulisher
Oct 12, 2024

Squarepoint Ops LLC Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Oct 12, 2024
pulisher
Oct 05, 2024

OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Renaissance Technologies LLC - Defense World

Oct 05, 2024
pulisher
Oct 04, 2024

American Century Companies Inc. Lowers Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Oct 04, 2024
pulisher
Oct 03, 2024

OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last? - Yahoo Finance

Oct 03, 2024
pulisher
Oct 02, 2024

Optimizerx stock hits 52-week low at $6.92 amid market shifts By Investing.com - Investing.com South Africa

Oct 02, 2024
pulisher
Oct 02, 2024

Optimizerx stock hits 52-week low at $6.92 amid market shifts - Investing.com Australia

Oct 02, 2024
pulisher
Sep 30, 2024

OptimizeRx's SWOT analysis: digital health firm faces growth challenges By Investing.com - Investing.com UK

Sep 30, 2024
pulisher
Sep 30, 2024

OptimizeRx's SWOT analysis: digital health firm faces growth challenges - Investing.com

Sep 30, 2024
pulisher
Sep 28, 2024

Rhumbline Advisers Increases Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Sep 28, 2024
pulisher
Sep 21, 2024

OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Bank of New York Mellon Corp - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Divisadero Street Capital Management LP Lowers Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Sep 20, 2024
pulisher
Sep 11, 2024

OptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by Rice Hall James & Associates LLC - MarketBeat

Sep 11, 2024
pulisher
Sep 10, 2024

OptimizeRx expands pharma client engagement to $10M - Investing.com

Sep 10, 2024
pulisher
Sep 10, 2024

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - The Tech Outlook

Sep 10, 2024
pulisher
Sep 10, 2024

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a - The Bakersfield Californian

Sep 10, 2024
pulisher
Sep 10, 2024

OptimizeRx Launches Novel Brand Eligibility Technology - Martechcube

Sep 10, 2024
pulisher
Sep 09, 2024

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences - ForexTV.com

Sep 09, 2024
pulisher
Sep 04, 2024

Down -12.46% in 4 Weeks, Here's Why OptimizeRx (OPRX) Looks Ripe for a Turnaround - Yahoo Finance

Sep 04, 2024
pulisher
Aug 18, 2024

OptimizeRx (NASDAQ:OPRX) Price Target Cut to $14.00 - Defense World

Aug 18, 2024
pulisher
Aug 14, 2024

Vanguard Group Inc. Raises Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Aug 14, 2024
pulisher
Aug 12, 2024

OptimizeRx (NASDAQ:OPRX) PT Lowered to $11.00 - Defense World

Aug 12, 2024
pulisher
Aug 12, 2024

A Closer Look at 5 Analyst Recommendations For OptimizeRx - Benzinga

Aug 12, 2024
pulisher
Aug 11, 2024

Earnings Release: Here's Why Analysts Cut Their OptimizeRx Corporation (NASDAQ:OPRX) Price Target To US$15.79 - Yahoo Finance

Aug 11, 2024
pulisher
Aug 10, 2024

OptimizeRx Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance UK

Aug 10, 2024
pulisher
Aug 10, 2024

Contrasting OptimizeRx (NASDAQ:OPRX) and Joint Stock Company Kaspi.kz (NASDAQ:KSPI) - Defense World

Aug 10, 2024
pulisher
Aug 09, 2024

Earnings call: OptimizeRx reports solid growth, misses revenue target - Investing.com

Aug 09, 2024
pulisher
Aug 09, 2024

OptimizeRx Corporation (NASDAQ:OPRX) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 09, 2024
pulisher
Aug 08, 2024

OptimizeRx Corp. (OPRX) Tops Q2 Earnings Estimates - MSN

Aug 08, 2024
pulisher
Aug 08, 2024

OptimizeRx Reports Second Quarter 2024 Financial Results - StockTitan

Aug 08, 2024
pulisher
Aug 08, 2024

Institutional investors may adopt severe steps after OptimizeRx Corporation's (NASDAQ:OPRX) latest 24% drop adds to a year losses - Yahoo Finance

Aug 08, 2024
pulisher
Aug 01, 2024

Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Misses Revenue Estimates - Zacks Investment Research

Aug 01, 2024
pulisher
Aug 01, 2024

OptimizeRx (OPRX) to Release Earnings on Thursday - MarketBeat

Aug 01, 2024
pulisher
Aug 01, 2024

OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Aug 01, 2024
pulisher
Aug 01, 2024

OptimizeRx (OPRX) Set to Announce Quarterly Earnings on Thursday - Defense World

Aug 01, 2024
pulisher
Jul 29, 2024

Acadian Asset Management LLC Cuts Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Jul 29, 2024
pulisher
Jul 29, 2024

Analysts Issue Forecasts for OptimizeRx Co.'s Q3 2024 Earnings (NASDAQ:OPRX) - MarketBeat

Jul 29, 2024
pulisher
Jul 29, 2024

Q3 2024 Earnings Estimate for OptimizeRx Co. (NASDAQ:OPRX) Issued By B. Riley - Defense World

Jul 29, 2024
pulisher
Jul 27, 2024

OptimizeRx Co. (NASDAQ:OPRX) Forecasted to Earn Q2 2024 Earnings of ($0.26) Per Share - Defense World

Jul 27, 2024
pulisher
Jul 26, 2024

OptimizeRx Co. (NASDAQ:OPRX) to Post Q2 2024 Earnings of ($0.26) Per Share, B. Riley Forecasts - MarketBeat

Jul 26, 2024
pulisher
Jul 25, 2024

OptimizeRx (NASDAQ:OPRX) Coverage Initiated by Analysts at B. Riley - MarketBeat

Jul 25, 2024
pulisher
Jul 25, 2024

OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET - ForexTV.com

Jul 25, 2024
pulisher
Jul 24, 2024

OptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by BNP Paribas Financial Markets - Defense World

Jul 24, 2024
pulisher
Jul 24, 2024

OptimizeRx adapts to US privacy laws for pharma marketing - Investing.com

Jul 24, 2024
pulisher
Jul 23, 2024

OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing ... - NRToday.com

Jul 23, 2024
pulisher
Jul 23, 2024

OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation - StockTitan

Jul 23, 2024
pulisher
Jul 21, 2024

RPC (NYSE:RES) Shares Down 4% - Defense World

Jul 21, 2024
pulisher
Jul 21, 2024

OptimizeRx Co. (NASDAQ:OPRX) Receives $16.00 Average Target Price from Analysts - MarketBeat

Jul 21, 2024

Optimizerx Corp Stock (OPRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Optimizerx Corp Stock (OPRX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Stelmakh Edward
CFO/COO
Oct 03 '24
Option Exercise
0.00
16,622
0
31,387
Odence-Ford Marion
General Counsel and CCO
Oct 03 '24
Option Exercise
0.00
6,649
0
25,147
Silvestro Stephen L
Chief Commercial Officer
Oct 03 '24
Option Exercise
0.00
6,649
0
79,495
Besch Doug
Chief Product Officer
Oct 03 '24
Option Exercise
0.00
3,324
0
11,172
FEBBO WILLIAM J
CEO
Apr 18 '24
Option Exercise
0.00
28,895
0
582,035
Spangler Patrick D
Director
Jun 05 '24
Option Exercise
0.00
10,061
0
32,181
Vos Ellen O'Connor
Director
Jun 05 '24
Option Exercise
0.00
10,061
0
49,488
WASSON GREGORY D
Director
Jun 05 '24
Option Exercise
0.00
10,061
0
34,029
HALAS GUS D
Director
Jun 05 '24
Option Exercise
0.00
10,061
0
80,926
Lang James Paul
Director
Jun 05 '24
Option Exercise
0.00
10,061
0
54,758
$49.80
price up icon 2.66%
health_information_services EVH
$23.57
price up icon 0.90%
$17.63
price up icon 4.88%
health_information_services WAY
$29.01
price up icon 1.26%
health_information_services RCM
$14.27
price down icon 0.07%
health_information_services TEM
$44.50
price down icon 10.10%
Cap:     |  Volume (24h):